Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Sees Significant Drop in Short Interest

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) saw a large decline in short interest during the month of January. As of January 15th, there was short interest totaling 21,391 shares, a decline of 32.6% from the December 31st total of 31,742 shares. Based on an average trading volume of 20,233 shares, the short-interest ratio is currently 1.1 days. Approximately 0.0% of the company’s stock are sold short. Approximately 0.0% of the company’s stock are sold short. Based on an average trading volume of 20,233 shares, the short-interest ratio is currently 1.1 days.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Zhengye Biotechnology in a report on Friday, January 9th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Institutional Trading of Zhengye Biotechnology

Several institutional investors have recently made changes to their positions in the business. Citadel Advisors LLC bought a new position in shares of Zhengye Biotechnology during the 3rd quarter valued at approximately $31,000. Millennium Management LLC purchased a new stake in Zhengye Biotechnology during the third quarter valued at $38,000. WINTON GROUP Ltd bought a new position in Zhengye Biotechnology during the third quarter valued at $56,000. Geode Capital Management LLC bought a new position in Zhengye Biotechnology during the second quarter valued at $174,000. Finally, Invesco Ltd. purchased a new position in shares of Zhengye Biotechnology in the 2nd quarter worth $220,000.

Zhengye Biotechnology Price Performance

NASDAQ ZYBT opened at $0.98 on Friday. The business’s fifty day moving average is $1.55 and its 200 day moving average is $3.95. Zhengye Biotechnology has a fifty-two week low of $0.90 and a fifty-two week high of $14.30. The company has a current ratio of 1.49, a quick ratio of 1.10 and a debt-to-equity ratio of 0.01.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.